SCHEMBL6901350

SCHEMBL6901350

C=CC(=O)Nc1ccc(SN2CCN(c3cccc4nc(C)ccc34)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 16/20 0.49
▸ HTR1D P28221 16/20 0.49
▸ HTR1B P28222 16/20 0.49
▸ DRD2 P14416 5/20 0.49
▸ HTR7 P34969 5/20 0.49
▸ DRD3 P35462 5/20 0.49
▸ KCNH2 Q12809 4/20 0.49
▸ HTR6 P50406 1/20 0.49
▸ HTR2A P28223 4/20 0.47
▸ HTR2C P28335 4/20 0.47
▸ HTR2B P41595 4/20 0.47
▸ F13A1 P00488 1/20 0.46
▸ TGM2 P21980 1/20 0.46
▸ TGM1 P22735 1/20 0.46
▸ TGM3 Q08188 1/20 0.46
▸ CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1877511 0.82 F13A1 (0.70) F13A1TGM2TGM1TGM3
SCHEMBL4178112 0.71 NCF1 (0.59) HTR1AHTR1DHTR1BDRD2HTR7
SCHEMBL6901428 0.70 LMNA (0.48) F13A1TGM2TGM1TGM3
SCHEMBL6901071 0.69 TGM2 (0.59) F13A1TGM2TGM1TGM3
SCHEMBL6902507 0.68 TGM2 (0.65) F13A1TGM2TGM1TGM3
SCHEMBL13525141 0.68 CYP2C9 (0.67) HTR1AHTR1DHTR1BDRD2HTR7
SCHEMBL10516997 0.68 NCF1 (0.65) HTR1AHTR1DHTR1BDRD2HTR7
SCHEMBL6899848 0.67 TGM2 (0.62) F13A1TGM2TGM1TGM3
SCHEMBL6900651 0.67 MEN1 (0.48) HTR2CF13A1TGM2TGM1TGM3
SCHEMBL28139077 0.67 NCF1 (0.68) HTR1AHTR1DHTR1BKCNH2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011060321-A1 TRANSGLUTAMINASE TG2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF CHDI, INC. (US) 2011-05-19 — — WO disclosed
Send feedback